Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now early-phase tilt small index

Arrhythmias, Cardiac: early-phase trial registry

5 of 18 indexed Arrhythmias, Cardiac trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #953 of 28,707 conditions by registered trial count.

18 US clinical trials · 5 currently recruiting · #953 of 28,707 conditions by registered trial count

Arrhythmias, Cardiac: 18 US clinical trials tracked, 5 recruiting.

Arrhythmias, Cardiac is the subject of 18 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Stanford University, running 2 of these trials.

Enrollment posture brief

Registry condition arrhythmias-cardiac

OPEN 5 | RECR 28% | LATE 0 | EARLY 1 | RANK #953 | SPON 2

Nearest open-share peer: Diabetic Peripheral Neuropathy (28% recruiting · 18 trials)

Atrial Fibrillation66.7%Arrhythmias, Cardiac (this)28%Androgenetic Alopecia16.7%Anemia, Sickle Cell16.7%Acquired Immunodeficiency Sy5.6%
Open-enrollment share among volume-matched conditions near Arrhythmias, Cardiac

Arrhythmias, Cardiac lists 5 open slots (28% of 18 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Arrhythmias, Cardiac on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Arrhythmias, Cardiac is recruiting below its size-band peers.

    5 of 18 indexed trials (27.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Arrhythmias, Cardiac trials is spread across many organizations.

    Stanford University accounts for 2 of 18 trials (11.1%). 17 distinct sponsors appear on at least one study for this condition label.

  3. Typical Arrhythmias, Cardiac enrolment sits around 124 participants.

    Median target enrolment is 124 among the 18 trials that report a genuine target (sentinel values excluded). 5 of those (27.8%) plan for fewer than 100 participants.

  4. Arrhythmias, Cardiac research leans observational.

    7 interventional and 11 observational studies make up this index (38.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21

Open and recent trials

18 total, page 1 of 1

RECRUITING 2,000 participants

Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic

The Cleveland Clinic

NCT00921986

RECRUITING 200 participants

The Dynamics of Human Atrial Fibrillation

Stanford University

NCT05366361

RECRUITING NA 120 participants

Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial Fibrillation

Icahn School of Medicine at Mount Sinai

NCT06938412

RECRUITING 120 participants

Machine Learning in Atrial Fibrillation

Stanford University

NCT05371405

RECRUITING 110 participants

AI Powered Mapping Technology for Identifying Arrhythmias

Heart Rhythm Clinical and Research Solutions

NCT06939478

ACTIVE NOT RECRUITING 1,000 participants

Cardiac Implantable Electronic Device (CIED) Research Study

Medtronic Cardiac Rhythm and Heart Failure

NCT05061862

ACTIVE NOT RECRUITING NA 400 participants

RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.

Cortex

NCT05883631

ACTIVE NOT RECRUITING NA 300 participants

Assessment of Combined CCM and ICD Device in HFrEF

Impulse Dynamics

NCT05855135

ACTIVE NOT RECRUITING 232 participants

Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring

Everbeat

NCT06892938

ACTIVE NOT RECRUITING NA 120 participants

Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation

University of Rochester

NCT04922281

ACTIVE NOT RECRUITING 62 participants

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

University of Texas Southwestern Medical Center

NCT02791880

ACTIVE NOT RECRUITING Phase 2 34 participants

Evaluation of PET/MR in Patients Selected for Ablation Therapy

Massachusetts General Hospital

NCT03265431

COMPLETED 4,163 participants

Evaluation of ECG Transmission and AI Models Using Apple Watch ECGs and Symptoms Data Collected Using a Mayo iPhone App

Mayo Clinic

NCT05324566

COMPLETED 500 participants

CanGaroo® Registry Study

Elutia

NCT04846127

COMPLETED 124 participants

Study to Monitor Patients With Pacemakers or ICDs Who Undergo MRI Scans

Essentia Health

NCT01999751

COMPLETED NA 35 participants

Prospective Elimination Of Distal Coronary Sinus-Left Atrial Connections for Atrial Fibrillation Ablation Trial

University of Pennsylvania

NCT03646643

COMPLETED 25 participants

AF-FLOW Registry to Evaluate Electrographic Flow Mapping in Patients Undergoing Ablation for Atrial Fibrillation

Ablacon

NCT05481359

COMPLETED NA 17 participants

Evaluation of the Use of Apple Watch Features for Identification of Cardiac Arrhythmias

Apple

NCT03769207

Phase Distribution

PhaseTrial count
Phase 2 1

Top Sponsors

Named interventions

Most-linked intervention names on Arrhythmias, Cardiac records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Electrographic Flow™ (EGF) mapping and ablation Device
1 trials
Coronary sinus to left atrium connection elimination Procedure
1 trials
Standard Atrial fibrillation ablation Procedure
1 trials
Ambulatory ECG Device
1 trials
CanGaroo Envelope Device
1 trials
MRI Scan Device
1 trials
Electrographic Flow (EGF) mapping (no ablation) Device
1 trials
Electrographic Flow (EGF) mapping and ablation of EGF-identified sources of Atrial Fibrillation Device
1 trials

US sites by state

Facility locations filed on Arrhythmias, Cardiac trials. A trial with sites in several states counts in each.

California 6 trials
Pennsylvania 5 trials
Florida 5 trials
Ohio 4 trials
New York 4 trials
Massachusetts 3 trials
Georgia 3 trials
Virginia 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Arrhythmias, Cardiac page

18 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 5 Arrhythmias, Cardiac trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Stanford University sponsors the most Arrhythmias, Cardiac trials on record, review their full trial history before evaluating a specific study. See Stanford University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Arrhythmias, Cardiac condition card totals 18 registered trials; most-linked intervention Electrographic Flow™ (EGF) mapping and ablation; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.